To Study Clinical Effectiveness and Safety of Olaparib Monotherapy in Metastatic Breast Cancer Patients.
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Olaparib
Related studies linked through entity extraction aliases.
Study Evaluating the Efficacy of Maintenance Olaparib and Cediranib or Olaparib Alone in Ovarian Cancer Patients
- Status
- UNKNOWN
- Phase
- PHASE3
Study of Olaparib Maintenance Following Cabazitaxel-Carbo in Men With AVPC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Olaparib and High-Dose Chemotherapy in Treating Patients With Relapsed or Refractory Lymphomas Undergoing Stem Cell Transplant
- Status
- COMPLETED
- Phase
- PHASE1
Olaparib for PAH: a Pilot Study
- Status
- TERMINATED
- Phase
- EARLY_PHASE1
Efficacy and Safety of Precision Therapy in Refractory Tumor
- Status
- UNKNOWN
- Phase
- PHASE2
Olaparib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Defects in DNA Damage Repair Genes (A Pediatric MATCH Treatment Trial)
- Status
- COMPLETED
- Phase
- PHASE2
Phase I/IIa Study of Concomitant Radiotherapy With Olaparib and Temozolomide in Unresectable High Grade Gliomas Patients
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Olaparib in Treating Patients With Advanced Glioma, Cholangiocarcinoma, or Solid Tumors With IDH1 or IDH2 Mutations
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Analysis of Olaparib Response in Patients With BRCA1 and/or 2 Promoter Methylation Diagnosed of Advanced Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
AZD5153 in Patients With Relapsed or Refractory Solid Tumors, Including Lymphomas
- Status
- COMPLETED
- Phase
- PHASE1
The UK Plasma Based Molecular Profiling of Advanced Breast Cancer to Inform Therapeutic CHoices (plasmaMATCH) Trial
- Status
- UNKNOWN
- Phase
- PHASE2
Selumetinib and Olaparib in Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Resistant Ovarian Cancer, Olaparib and Liposomal Doxorubicin
- Status
- COMPLETED
- Phase
- PHASE2
Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Platinum and Polyadenosine 5'Diphosphoribose Polymerisation Inhibitor for Neoadjuvant Treatment of Triple Negative Breast Cancer and/or Germline BRCA Positive Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
Study of Olaparib/Trabectedin vs. Doctor's Choice in Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE2
Olaparib +/- Cediranib or Chemotherapy in Patients With Platinum-resistant Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Olaparib & Radiation Therapy for Patients Triple Negative Breast Cancer (TNBC)
- Status
- COMPLETED
- Phase
- PHASE1
A Dye for the Detection of Cancer of the Tongue and Mouth
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2